MultiMedia Pharma Sciences
MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996, with 501-1000 employees and reported presence in Göttingen, Germany and Cranbury, United States.
- Company typePrivate
- Founded1996
- HeadquartersGöttingen, Germany
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What MultiMedia Pharma Sciences does
MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996. Per firmographic records, the company is headquartered in Göttingen, Germany, with a separately noted office location in Cranbury, United States; this geographic split suggests potential transatlantic operations, though the firmographic data is internally inconsistent and should be verified. The company employs 501-1000 staff, consistent with a mid-sized contract development and manufacturing organization (CDMO) or specialty biopharma manufacturer. The website URL listed (biopharminternational.com) corresponds to a third-party industry trade publication rather than a proprietary corporate site, which further limits visibility into the company's product portfolio and service offering.
No specific products, service lines, therapeutic areas, manufacturing platforms, or proprietary technologies are disclosed in the input data. The input material is drawn from BioPharm International's general industry coverage and does not contain company-specific content; structured fields for products and services, partnerships, certifications, management team, and corporate history are all empty. As a result, the company's precise positioning within the biopharma value chain — whether as a CDMO, a specialty drug developer, or a hybrid — cannot be determined from the available evidence.
The most recent documented capital-markets event is a 2012 funding round referencing Ingleside Investors as an investor (4th round overall), with no disclosed amount. No subsequent funding rounds, M&A activity, partnerships, product launches, or leadership changes are present in the input. The company is described as for-profit and private, with no IPO activity, parent company, or subsidiary structure disclosed. Overall, the data supports only a baseline description; deeper analytical claims about business model, revenue mechanics, or go-to-market strategy would require additional primary-source verification.
MultiMedia Pharma Sciences firmographics
Firmographics- Name
- MultiMedia Pharma Sciences
- Website
- https://biopharminternational.com
- Company type
- Private
- Founded year
- 1996
- Headcount range
- 501–1,000 employees
- Short description
- MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996, with 501-1000 employees and reported presence in Göttingen, Germany and Cranbury, United States.
- Ownership category
- akta.pro rank
MultiMedia Pharma Sciences industry classification
Industry- Product category
- Biopharmaceutical Manufacturing
- NAICS
- Broadcasting and Content Providers (516)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)
Keywords
Where MultiMedia Pharma Sciences is headquartered
LocationHeadquarters
- HQ city
- Göttingen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
MultiMedia Pharma Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
MultiMedia Pharma Sciences product offering
Product offeringCore offering
MultiMedia Pharma Sciences is a biopharmaceutical drug development and manufacturing company. It develops and produces pharmaceutical drug substances and finished products for the biopharmaceutical industry. The firm is headquartered in Göttingen, Germany, with operations in the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- Biopharmaceutical Drug Development and Manufacturing Services Drug development and manufacturing services for biopharmaceutical and pharmaceutical clients, covering drug substance and finished product production.
Companies that use MultiMedia Pharma Sciences
Customer profileIdeal customer profiles1 record
MultiMedia Pharma Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MultiMedia Pharma Sciences partnerships and signals
Strategic signalExpansion highlights1 record
MultiMedia Pharma Sciences competitors and assessment
Company assessmentOthers
- INTERPHEX (RX Global): Major pharmaceutical manufacturing conference explicitly referenced on the BioPharm International site; comparable as a biopharma manufacturing events franchise and a likely commercial partner.
Broad incumbents
- Citeline (formerly Pharma intelligence): Data and intelligence provider (Pink Sheet, Scrip, BioMedTracker) covering biopharma R&D, regulatory and clinical trials — competes for the same biopharma decision-maker audience and ad/sponsorship budget.
- BioSpace: Long-standing biopharma industry news, jobs and intelligence platform with significant overlap in biomanufacturing and drug development coverage for the same professional audience.
- Fierce Pharma: Large biopharma business news brand from Questex, covering pharma business, manufacturing and regulation at greater breadth — competes with BioPharm International for biopharma executive readership and ad spend.
- Pharmaceutical Executive: Trade title focused on pharmaceutical business strategy, regulation and manufacturing operations — overlaps with BioPharm International's BioBusiness and Regulatory/GMP coverage for pharma executive readers.
Direct peers
- PharmaTimes: UK-based pharmaceutical industry publication covering drug development, manufacturing and regulatory affairs — directly comparable in editorial scope and B2B positioning to BioPharm International.
- Outsourced Pharma: Niche trade publication focused on pharmaceutical outsourcing and CDMO services — a topic area heavily featured in BioPharm International's Outsourcing/Contract Manufacturing coverage.
- Drug Discovery & Development: B2B trade title focused on drug discovery, development and biopharma R&D pipelines — directly competes for the same pharmaceutical professional audience and advertiser base.
- Pharmaceutical Technology: Peer trade publication covering pharmaceutical development, manufacturing, formulation and regulatory topics — overlaps almost entirely with BioPharm International's coverage of drug substance, finished product and bioprocessing.
Emerging players
- Endpoints News: Digital-native biopharma news outlet that has rapidly captured advertising share and readership from legacy trade publications covering drug development and biopharma business.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights6 records
Customer concentration
MultiMedia Pharma Sciences social profiles
Digital presenceMultiMedia Pharma Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
MultiMedia Pharma Sciences leadership team
Management profileNumber of profiles
MultiMedia Pharma Sciences funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MultiMedia Pharma Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MultiMedia Pharma Sciences
What does MultiMedia Pharma Sciences do?
MultiMedia Pharma Sciences is a biopharmaceutical drug development and manufacturing company. It develops and produces pharmaceutical drug substances and finished products for the biopharmaceutical industry. The firm is headquartered in Göttingen, Germany, with operations in the United States.
When was MultiMedia Pharma Sciences founded?
MultiMedia Pharma Sciences was founded in 1996. It employs 501 to 1,000 people.
Where is MultiMedia Pharma Sciences based?
MultiMedia Pharma Sciences is headquartered in Göttingen, Germany, in the Europe region.
Who are MultiMedia Pharma Sciences's main competitors?
INTERPHEX (RX Global) is listed as an others. Broad incumbents are Citeline (formerly Pharma intelligence), BioSpace, Fierce Pharma and Pharmaceutical Executive. Direct peers are PharmaTimes, Outsourced Pharma, Drug Discovery & Development and Pharmaceutical Technology. Endpoints News is listed as an emerging player.
Does MultiMedia Pharma Sciences have an API?
No public API is recorded for MultiMedia Pharma Sciences.
What industry is MultiMedia Pharma Sciences in?
MultiMedia Pharma Sciences's product category is Biopharmaceutical Manufacturing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing. Its NAICS code is 516 and its SIC code is 2721.